An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Review of evidence on health aspects of air pollution – REVIHAAP Project: Technical Report [Internet].
WHO Regional Office for Europe.
Copenhagen: WHO Regional Office for Europe; 2013.
Top results in this bookTable of Contents
Selpercatinib (Retevmo): CADTH Reimbursement Review: Therapeutic area: RET fusion–positive non–small cell lung cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
Review of DOD's Approach to Deriving an Occupational Exposure Level for Trichloroethylene.
National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Environmental Studies and Toxicology; Committee to Review DOD's Approach to Deriving an Occupational Exposure Limit for TCE.
Washington (DC): National Academies Press (US); 2019 Nov 15.
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Melendez-Torres GJ, Auguste P, Armoiry X, et al.
Southampton (UK): NIHR Journals Library; 2017 Sep. (Health Technology Assessment, No. 21.52.)
Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet].
Michos ED, Berger Z, Yeh HC, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. (Comparative Effectiveness Review, No. 135.)
Catalyzing Inquiry at the Interface of Computing and Biology.
National Research Council (US) Committee on Frontiers at the Interface of Computing and Biology; Wooley JC, Lin HS, editors.
Washington (DC): National Academies Press (US); 2005.
Bladder Cancer: Diagnosis and Management.
National Collaborating Centre for Cancer (UK).
London: National Institute for Health and Care Excellence (NICE); 2015 Feb. (NICE Guideline, No. 2.)
Chronic Heart Failure in Adults: Diagnosis and Management.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Sep. (NICE Guideline, No. 106.)
Atogepant (Qulipta): CADTH Reimbursement Review: Therapeutic area: Migraine, prevention [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Aug.
Assay Guidance Manual [Internet].
Markossian S, Grossman A, Arkin M, et al., editors.
Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Evidence reviews for adjuvant bisphosphonates: Early and locally advanced breast cancer: diagnosis and management: Evidence review G.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Jul. (NICE Guideline, No. 101.)
Evidence review for preventing contrast-induced acute kidney injury: Acute kidney injury: prevention, detection and management: Evidence review A.
London: National Institute for Health and Care Excellence (NICE); 2019 Dec. (NICE Guideline, No. 148.)
Evidence review for following up people at risk of prostate cancer: Prostate cancer: diagnosis and management: Evidence review E.
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 131.)
Interventions and approaches to support looked-after young people transitioning out of care into independent living: Looked-After Children and Young People: Evidence review N.
London: National Institute for Health and Care Excellence (NICE); 2021 Oct. (NICE Guideline, No. 205.)
Evidence review for the best combination of measures to identify increased risk of progression in adults, children and young people: Chronic kidney disease: Evidence review F.
London: National Institute for Health and Care Excellence (NICE); 2021 Aug. (NICE Guideline, No. 203.)
Non-drug therapies for the management of chronic constipation in adults: the CapaCiTY research programme including three RCTs.
Knowles CH, Booth L, Brown SR, et al.
Southampton (UK): NIHR Journals Library; 2021 Nov. (Programme Grants for Applied Research, No. 9.14.)
Clinical Review Report: Emicizumab (Hemlibra): Hoffmann-La Roche Ltd. Indication: Bleeding prevention, hemophilia A [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Feb.
Modalities of RRT: Renal replacement therapy and conservative management: Evidence review.
London: National Institute for Health and Care Excellence (NICE); 2018 Oct. (NICE Guideline, No. 107.)
Evidence reviews for respiratory support: Specialist neonatal respiratory care for babies born preterm: Evidence review B.
London: National Institute for Health and Care Excellence (NICE); 2019 Apr. (NICE Guideline, No. 124.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on